查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年慢性病管理市场预测：按类型、疾病类型、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383405

到 2030 年慢性病管理市场预测：按类型、疾病类型、最终用户和地区进行的全球分析

Chronic Disease Management Market Forecasts to 2030 - Global Analysis By Type, Disease Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球慢性病管理市场规模为 63 亿美元，预计在预测期内将以 13.8% 的年复合成长率成长，到 2030 年达到 156 亿美元。

慢性病管理市场是一个处理糖尿病、心臟病和癌症等长期非传染性疾病的医疗保健部门。它包括旨在预防、监测和治疗这些疾病以改善患者生活品质的各种策略和技术。应用包括远端患者监测、个体化治疗计划和资料驱动的主导。

根据 NCBI 的数据，慢性病约占死亡原因的 60% 和全球疾病负担的 43%。

人口高龄化加剧

随着人口结构转向老化趋势转变，慢性病的盛行率正在增加。这种人口趋势给医疗保健系统和资源带来了巨大压力，需要加强疾病管理策略。对慢性病的专业照护、预防措施和长期支持的需求不断增加，推动了客製化医疗解决方案和技术的发展。解决人口高龄化的医疗保健需求不仅会改善老年人的生活质量，而且在提供有效和高效的护理、推动慢性病管理市场的成长方面也变得越来越重要。

实施先进的计划是昂贵的

最尖端科技、远端监控系统和个体化治疗解决方案的开发和实施往往需要大量的财务投资。医疗保健组织和提供者经常面临预算限制以及分配资源来部署昂贵技术的挑战。此外，这些费用可能会增加患者负担并限制获得先进的慢性病管理。经济负担也会阻碍小型医疗机构和服务不足的社区提供全面的疾病管理服务，从而加剧健康差距。减少这些成本障碍对于确保公平获得有效的慢性病管理解决方案至关重要。

政府医疗保健政策和奖励

世界各地许多政府都认识到慢性病增加对经济和公共卫生的影响。因此，我们实施了鼓励开发和采用创新疾病管理解决方案的政策。奖励包括财政支持、报销计划和法律规范，以促进将技术和远端医疗纳入卫生系统，并使提供者更容易提供有效的慢性病管理服务。此类政策不仅促进市场成长，还有助于改善医疗保健的可及性、降低医疗保健成本并改善患者的治疗效果，为医疗相关人员和患者创造双赢的局面。

严格的法规和合规要求

法规对于确保病患安全和资料安全至关重要，但过于复杂和限制性的法规环境会抑制创新，并可能阻碍管理慢性病的新技术和解决方案的快速开发和部署。合规性挑战会增加将产品推向市场的时间和成本，并为公司和医疗保健提供者製造障碍。此外，复杂的法规环境可能会阻碍市场进入、限制竞争并限制先进慢性病管理解决方案的使用，最终影响病患照护和医疗保健系统，影响效率。

COVID-19 的影响：

COVID-19 的疫情对慢性病管理市场产生了重大影响。由于医疗保健系统专注于应对这一流行病，常规慢性病护理已被打乱。远端医疗和远端监控解决方案越来越受到关注，以最大限度地减少现场就诊并降低弱势群体的暴露风险。然而，由于资源被转用于与大流行相关的配合措施，并且常规筛检和治疗被推迟，未控制的慢性病的数量可能会增加，引发人们对长期健康影响的担忧。这场大流行加速了数位健康解决方案的采用，并凸显了对有弹性和适应性的慢性病管理策略的需求。

在预测期内，服务业预计将是最大的。

预计服务业市场将出现良好成长。该市场的服务包括广泛的医疗保健服务，旨在满足患有长期健康问题的个人的需求。这些服务包括疾病预防和教育、诊断测试、治疗计划、药物管理和生活方式咨询。医疗保健提供者正在利用远端监控、远端医疗咨询和资料主导干预等技术来提供以患者为中心的护理，以有效追踪和管理慢性病。支持团体和心理健康服务在解决慢性病患者的情绪和心理方面也发挥着重要作用。

预计糖尿病产业在预测期内年复合成长率最高

预计糖尿病领域在预测期内将以最快的年复合成长率成长。由于其广泛盛行率和综合管理的需要，糖尿病已成为慢性病的焦点。这种以高血糖值为特征的慢性疾病需要持续监测、生活方式调整，通常还需要药物和胰岛素治疗。医疗保健提供者和数数位健康解决方案提供各种服务，包括血糖监测设备、糖尿病教育计划、个人化用餐和运动计划以及远距医疗咨询。目的是帮助糖尿病患者更好地管理他们的病情，降低併发症的风险并提高他们的整体生活品质。

占比最高的地区

预计北美市场在预测期内将继续占据大部分市场占有率。该地区包括美国和加拿大，高龄化、文明病和慢性病负担的增加正在推动对创新疾病管理解决方案的需求。远端医疗、穿戴式装置和电子健康记录越来越多地被采用，从而实现远端监控和个人化护理。此外，在北美，政府政策和医疗保健法规经常鼓励慢性病管理计划的製定和实施，从而促进医疗保健创新的发展，重点是改善患者的治疗结果和减少慢性病的经济影响。 。

复合年复合成长率最高的地区：

预计亚太地区在预测期内年复合成长率最高。该地区人口众多、中阶不断壮大以及生活方式的改变正在增加糖尿病、心血管疾病和呼吸系统疾病等慢性病的盛行率。医疗保健提供者和技术公司正在积极推出疾病预防、监测和治疗的创新解决方案。远端医疗服务、行动健康应用程式和远端监控设备越来越受欢迎，尤其是在中国和印度等国家。政府旨在改善医疗保健可近性和提高患者对管理慢性病重要性的认识的配合措施正在促进市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球慢性病管理市场：依类型

  • 解决方案
    • 本地解决方案
    • 云端基础的解决方案
    • 基于网路的
  • 服务
    • 咨询服务
    • 实施服务
    • 教育服务
  • 其他类型

第6章全球慢性病管理市场：依疾病类型

  • 心血管疾病
  • 糖尿病
  • 癌症
  • 气喘
  • 慢性阻塞性肺病
  • 其他类型的疾病

第7章全球慢性病管理市场：依最终使用者分类

  • 医疗服务提供方
  • 医疗保健付款人
  • 其他最终用户

第8章全球慢性病管理市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • HealthSmart Holdings, Inc.
  • Vivify Health, Inc
  • Medecision, Inc.
  • Pegasystems Inc.
  • Allscripts Healthcare Solutions, Inc.
  • Altruista Health
  • AxisPoint Health
  • Epic Corporation Inc.
  • TriZetto Corporation
  • EXL Healthcare
  • ZeOmega Inc.
  • Health Catalyst
Product Code: SMRC24254

According to Stratistics MRC, the Global Chronic Disease Management Market is accounted for $6.3 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 13.8% during the forecast period. The Chronic Disease Management Market is the healthcare sector dedicated to addressing long-term, non-communicable health conditions such as diabetes, heart disease, and cancer. It involves a range of strategies and technologies aimed at preventing, monitoring, and treating these conditions to improve patients' quality of life. Its uses include remote patient monitoring, personalized treatment plans, and data-driven interventions.

According to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden.

Market Dynamics:

Driver:

Increasing of aging population

As demographics shift towards an older populace, there is a heightened prevalence of chronic diseases, as many of these conditions become more common with age. This demographic trend places a substantial burden on healthcare systems and resources, necessitating enhanced disease management strategies. The demand for specialized care, preventive measures, and long-term support for chronic illnesses is on the rise, fostering the development of tailored healthcare solutions and technologies. Addressing the healthcare needs of the aging population not only improves their quality of life but also drives the growth of the chronic disease management market as it becomes increasingly essential in providing effective and efficient care.

Restraint:

Implementations of advanced programs are expensive

Developing and deploying cutting-edge technologies, remote monitoring systems, and personalized treatment solutions often require substantial financial investments. Healthcare organizations and providers may be constrained by budget limitations and face challenges in allocating resources for the adoption of expensive technologies. Additionally, these costs can translate to higher expenses for patients, limiting their access to advanced chronic disease management. The financial burden may also deter smaller healthcare facilities and underserved regions from offering comprehensive disease management services, potentially exacerbating health disparities. Mitigating these cost barriers is essential to ensure equitable access to effective chronic disease management solutions.

Opportunity:

Government healthcare policies and incentives

Many governments worldwide are recognizing the economic and public health implications of rising chronic disease burdens. As a result, they are implementing policies that encourage the development and adoption of innovative disease management solutions. Incentives may include financial support, reimbursement programs, and regulatory frameworks that promote the integration of technology and telehealth into healthcare systems, making it easier for providers to offer effective chronic disease management services. These policies not only stimulate market growth but also contribute to better access to care, reduced healthcare costs, and improved patient outcomes, creating a win-win scenario for healthcare stakeholders and patients alike.

Threat:

Stringent regulations and compliance requirements

While regulations are essential for ensuring patient safety and data security, an overly complex and restrictive regulatory environment can impede innovation and hinder the rapid development and deployment of new technologies and solutions for managing chronic diseases. Compliance challenges can increase the time and cost of bringing products to market, creating barriers for businesses and healthcare providers. Additionally, navigating a complex regulatory landscape may deter some companies from entering the market, limiting competition and potentially limiting the availability of advanced chronic disease management solutions, ultimately impacting patient care and healthcare system efficiency.

COVID-19 Impact:

The COVID-19 pandemic has had a profound impact on the Chronic Disease Management Market. With healthcare systems focused on responding to the pandemic, there has been a disruption in routine chronic disease care. Telemedicine and remote monitoring solutions gained prominence to minimize in-person visits and reduce exposure risks for vulnerable populations. However, the diversion of resources towards pandemic-related efforts and delays in routine screenings and treatments has led to a potential increase in unmanaged chronic conditions, which may have long-term health implications. The pandemic has accelerated the adoption of digital health solutions while highlighting the need for resilient and adaptable chronic disease management strategies.

The services segment is expected to be the largest during the forecast period

The services segment is expected to have lucrative growth in the market. Services in the market encompass a wide range of healthcare offerings tailored to address the needs of individuals dealing with long-term health conditions. These services include disease prevention and education, diagnostic testing, treatment planning, medication management, and lifestyle counseling. Healthcare providers offer patient-centered care by leveraging technology for remote monitoring, telehealth consultations, and data-driven interventions to track and manage chronic diseases effectively. Support groups and mental health services also play a vital role in addressing the emotional and psychological aspects of living with a chronic condition.

The diabetes segment is expected to have the highest CAGR during the forecast period

The diabetes segment is anticipated to witness the fastest CAGR growth during the forecast period. Diabetes is a central focus in the chronic disease, given its widespread prevalence and the need for comprehensive management. This chronic condition, characterized by high blood sugar levels, requires ongoing monitoring, lifestyle adjustments, and often medication or insulin therapy. Healthcare providers and digital health solutions offer a range of services, including glucose monitoring devices, diabetic education programs, personalized dietary and exercise plans, and telehealth consultations. The goal is to empower individuals with diabetes to better manage their condition, reduce the risk of complications, and improve their overall quality of life.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region encompasses the United States and Canada, where the aging population, lifestyle-related diseases, and the rising burden of chronic illnesses drive the demand for innovative disease management solutions. The adoption of telehealth, wearable devices, and electronic health records is widespread, enabling remote monitoring and personalized care. Additionally, government policies and healthcare regulations in North America often encourage the development and implementation of chronic disease management programs, making it a fertile ground for healthcare innovation, with a focus on improving patient outcomes and reducing the economic impact of chronic diseases.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The region's significant population, rising middle class and lifestyle changes have led to an increasing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders. Healthcare providers and technology companies are actively introducing innovative solutions for disease prevention, monitoring, and treatment. Telehealth services, mobile health apps, and remote monitoring devices are gaining traction, especially in countries like China and India. Government initiatives to improve healthcare access and the growing awareness among patients about the importance of managing chronic conditions contribute to the market's expansion.

Key players in the market

Some of the key players in Chronic Disease Management market include: HealthSmart Holdings, Inc., Vivify Health, Inc, Medecision, Inc., Pegasystems Inc., Allscripts Healthcare Solutions, Inc., Altruista Health, AxisPoint Health, Epic Corporation Inc., TriZetto Corporation, EXL Healthcare, ZeOmega Inc. and Health Catalyst.

Key Developments:

In January 2023, MedStar Health and Zephyr AI, Inc. a start-up specializing in precision medicine technology announced their partnership to work to improve outcomes for chronic diseases, beginning with type 2 diabetes (T2D).

In October 2022, Enli Health Intelligence, a supplier of digital solutions for population health management, was acquired by Cedar Gate Technologies. With the addition of cohort, population, and patient management technologies, risk & quality indicators, gaps in care identification, and patient outreach opportunities, Cedar Gate's enterprise value-based care platform was intended to be expanded for improved outcomes and long-term financial viability.

Types Covered:

  • Solutions
  • Services
  • Other Types

Disease Types Covered:

  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • Asthma
  • Chronic Obstructive Pulmonary Disorders
  • Other Disease Types

End Users Covered:

  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Chronic Disease Management Market, By Type

  • 5.1 Introduction
  • 5.2 Solutions
    • 5.2.1 On-Premise Solution
    • 5.2.2 Cloud-Based Solution
    • 5.2.3 Web-Based
  • 5.3 Services
    • 5.3.1 Consulting Services
    • 5.3.2 Implementation Services
    • 5.3.3 Educational Services
  • 5.4 Other Types

6 Global Chronic Disease Management Market, By Disease Type

  • 6.1 Introduction
  • 6.2 Cardiovascular Diseases
  • 6.3 Diabetes
  • 6.4 Cancer
  • 6.5 Asthma
  • 6.6 Chronic Obstructive Pulmonary Disorders
  • 6.7 Other Disease Types

7 Global Chronic Disease Management Market, By End User

  • 7.1 Introduction
  • 7.2 Healthcare Providers
  • 7.3 Healthcare Payers
  • 7.4 Other End Users

8 Global Chronic Disease Management Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 HealthSmart Holdings, Inc.
  • 10.2 Vivify Health, Inc
  • 10.3 Medecision, Inc.
  • 10.4 Pegasystems Inc.
  • 10.5 Allscripts Healthcare Solutions, Inc.
  • 10.6 Altruista Health
  • 10.7 AxisPoint Health
  • 10.8 Epic Corporation Inc.
  • 10.9 TriZetto Corporation
  • 10.10 EXL Healthcare
  • 10.11 ZeOmega Inc.
  • 10.12 Health Catalyst

List of Tables

  • Table 1 Global Chronic Disease Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 4 Global Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 5 Global Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 6 Global Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 7 Global Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 8 Global Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 9 Global Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 10 Global Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 11 Global Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 12 Global Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 13 Global Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 14 Global Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 15 Global Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 16 Global Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 17 Global Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 18 Global Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 19 Global Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 21 Global Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 22 Global Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 26 North America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 27 North America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 28 North America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 29 North America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 30 North America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 31 North America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 32 North America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 33 North America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 34 North America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 35 North America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 36 North America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 37 North America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 38 North America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 39 North America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 40 North America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 41 North America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 43 North America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 44 North America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 48 Europe Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 49 Europe Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 50 Europe Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 51 Europe Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 52 Europe Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 53 Europe Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 54 Europe Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 55 Europe Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 56 Europe Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 57 Europe Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 58 Europe Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 59 Europe Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 60 Europe Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 61 Europe Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 62 Europe Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 63 Europe Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 65 Europe Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 66 Europe Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 70 Asia Pacific Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 71 Asia Pacific Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 72 Asia Pacific Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 73 Asia Pacific Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 74 Asia Pacific Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 75 Asia Pacific Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 76 Asia Pacific Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 77 Asia Pacific Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 78 Asia Pacific Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 79 Asia Pacific Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 80 Asia Pacific Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 81 Asia Pacific Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 82 Asia Pacific Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 83 Asia Pacific Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 84 Asia Pacific Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 85 Asia Pacific Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 87 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 88 Asia Pacific Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 92 South America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 93 South America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 94 South America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 95 South America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 96 South America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 97 South America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 98 South America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 99 South America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 100 South America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 101 South America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 102 South America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 103 South America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 104 South America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 105 South America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 106 South America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 107 South America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 112 South America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 113 South America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 114 Middle East & Africa Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
  • Table 115 Middle East & Africa Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
  • Table 116 Middle East & Africa Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
  • Table 117 Middle East & Africa Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
  • Table 118 Middle East & Africa Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
  • Table 119 Middle East & Africa Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
  • Table 120 Middle East & Africa Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
  • Table 121 Middle East & Africa Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 122 Middle East & Africa Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
  • Table 123 Middle East & Africa Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
  • Table 124 Middle East & Africa Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 125 Middle East & Africa Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
  • Table 126 Middle East & Africa Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 127 Middle East & Africa Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 128 Middle East & Africa Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 129 Middle East & Africa Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
  • Table 130 Middle East & Africa Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
  • Table 131 Middle East & Africa Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
  • Table 132 Middle East & Africa Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 133 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 134 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
  • Table 135 Middle East & Africa Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)